Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Baxter Submits European Marketing Authorization Application For HyQ, an Investigational IG Therapy for Primary Immunodeficiencies
Baxter Submits European Marketing Authorization Application For HyQ, an Investigational IG Therapy for Primary Immunodeficiencies
Baxter Submits European Marketing Authorization Application For HyQ, an Investigational IG Therapy for Primary Immunodeficiencies
Submitted by
moderatorj
on September 30, 2011 - 6:12pm
Source:
Yahoo/BusinessWire
News Tags:
Baxter
European
EU
therapy
Headline:
Baxter Submits European Marketing Authorization Application For HyQ, an Investigational IG Therapy for Primary Immunodeficiencies
Do Not Allow Advertisers to Use My Personal information
